FXN (Frataxin) mouse monoclonal antibody, clone OTI4G4 (formerly 4G4)
| Applications | IF, WB |
| Reactivities | Human |
Products
FXN (Frataxin) mouse monoclonal antibody, clone OTI3B6 (formerly 3B6)
| Applications | IF, WB |
| Reactivities | Human |
Transient overexpression lysate of frataxin (FXN), nuclear gene encoding mitochondrial protein, transcript variant 1
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
FXN mouse monoclonal capture antibody, validated for Luminex assays
| Applications | LMNX |
| Reactivities | Human |
FXN mouse monoclonal capture antibody, validated for Luminex assays
| Applications | LMNX |
| Reactivities | Human |
FXN mouse monoclonal capture antibody, validated for Luminex assays
| Applications | LMNX |
| Reactivities | Human |
FXN (Frataxin) mouse monoclonal antibody, clone OTI4D7 (formerly 4D7)
| Applications | WB |
| Reactivities | Human |
FXN (Frataxin) mouse monoclonal antibody, clone OTI3F3 (formerly 3F3)
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) FXN mouse monoclonal antibody, clone OTI3C3 (formerly 3C3)
| Applications | IF, WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) FXN mouse monoclonal antibody, clone OTI4G4 (formerly 4G4)
| Applications | IF, WB |
| Reactivities | Human |
CNY 3990.00
2周
FXN (Frataxin) mouse monoclonal antibody, clone OTI1F2 (formerly 1F2), Biotinylated
| Applications | FC, WB |
| Reactivities | Human |
CNY 3990.00
2周
FXN (Frataxin) mouse monoclonal antibody, clone OTI1F2 (formerly 1F2), HRP conjugated
| Applications | FC, WB |
| Reactivities | Human |
FXN - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
CNY 3990.00
2周
FXN (Frataxin) mouse monoclonal antibody, clone OTI3C3 (formerly 3C3), Biotinylated
| Applications | IF, WB |
| Reactivities | Human |
CNY 3990.00
2周
FXN (Frataxin) mouse monoclonal antibody, clone OTI3B6 (formerly 3B6), Biotinylated
| Applications | IF, WB |
| Reactivities | Human |
